Variant report
Variant | esv3528786 |
---|---|
Chromosome Location | chr19:56274119-56289998 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:112)
- CpG islands (count:61)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr19:56274428-56274478 | NHDF-neo | bronchial: | n/a |
2 | chr19:56274428-56274478 | HUVEC | blood vessel: | n/a |
3 | chr19:56274428-56274478 | AG09319 | gingival: | n/a |
4 | chr19:56274428-56274478 | HRE | kidney: | n/a |
5 | chr19:56274428-56274478 | HIPEpiC | eye: | n/a |
6 | chr19:56274428-56274478 | AG04449 | skin: | fetal |
7 | chr19:56274428-56274478 | GM06990 | blood: | n/a |
8 | chr19:56274428-56274478 | HEK293 | kidney: | embryo |
9 | chr19:56274428-56274478 | PFSK-1 | brain: | n/a |
10 | chr19:56274428-56274478 | NT2-D1 | testis: | n/a |
11 | chr19:56274428-56274478 | IMR90 | lung: | fetal |
12 | chr19:56274428-56274478 | Hela-S3 | cervix: | n/a |
13 | chr19:56274428-56274478 | ProgFib | skin: | n/a |
14 | chr19:56274428-56274478 | NB4 | blood: | n/a |
15 | chr19:56274428-56274478 | HepG2 | liver: | n/a |
16 | chr19:56274428-56274478 | BE2_C | brain: | n/a |
17 | chr19:56274428-56274478 | T-47D | breast: | n/a |
18 | chr19:56274428-56274478 | NHBE | bronchial: | n/a |
19 | chr19:56274428-56274478 | HAEpiC | amniotic membrane: | n/a |
20 | chr19:56274428-56274478 | GM12892 | blood: | n/a |
21 | chr19:56274428-56274478 | HMEC | breast: | n/a |
22 | chr19:56274428-56274478 | HCPEpiC | choroid plexus: | n/a |
23 | chr19:56274428-56274478 | SK-N-SH | brain: | n/a |
24 | chr19:56274428-56274478 | HRCEpiC | kidney: | n/a |
25 | chr19:56274428-56274478 | ECC-1 | luminal epithelium: | n/a |
26 | chr19:56274428-56274478 | HNPCEpiC | eye: | n/a |
27 | chr19:56274428-56274478 | AoSMC | blood vessel: | n/a |
28 | chr19:56274428-56274478 | HCT-116 | colon: | n/a |
29 | chr19:56274428-56274478 | GM12878 | blood: | n/a |
30 | chr19:56274428-56274478 | Hepatocyte | liver: | n/a |
31 | chr19:56274428-56274478 | ovcar-3 | ovarian: | n/a |
32 | chr19:56274428-56274478 | RPTEC | kidney: | n/a |
33 | chr19:56274428-56274478 | PANC-1 | pancreas: | n/a |
34 | chr19:56274428-56274478 | A549 | lung: | n/a |
35 | chr19:56274428-56274478 | H1-hESC | embryonic stem cell: | embryo |
36 | chr19:56274428-56274478 | AG04450 | lung: | fetal |
37 | chr19:56274428-56274478 | SAEC | small airway: | n/a |
38 | chr19:56274428-56274478 | AG09309 | skin: | n/a |
39 | chr19:56274428-56274478 | BJ | skin: | n/a |
40 | chr19:56274428-56274478 | HCF | heart: | n/a |
41 | chr19:56274428-56274478 | SK-N-MC | brain: | n/a |
42 | chr19:56274428-56274478 | MCF10A-Er-Src | breast: | n/a |
43 | chr19:56274428-56274478 | HPAEpiC | pulmonary alveolar: | n/a |
44 | chr19:56274428-56274478 | Caco-2 | colon: | n/a |
45 | chr19:56274428-56274478 | HCM | heart: | n/a |
46 | chr19:56274428-56274478 | MCF-7 | breast: | n/a |
47 | chr19:56274428-56274478 | NH-A | brain: | n/a |
48 | chr19:56274428-56274478 | PrEC | prostate: | n/a |
49 | chr19:56274428-56274478 | GM19239 | blood: | n/a |
50 | chr19:56274428-56274478 | U87 | brain: | n/a |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
RFPL4AL1 | TF binding region |
RFPL4AP1 | TF binding region |
RFPL4AL1 | CpG island |
RFPL4AP1 | CpG island |
ENSG00000188825 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs531697521 | chr19:56276476-56276477 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs538568128 | chr19:56276489-56276490 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs558109534 | chr19:56276537-56276538 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs200865210 | chr19:56276546-56276547 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs561995393 | chr19:56276547-56276548 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs139096112 | chr19:56276549-56276550 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs574930091 | chr19:56276604-56276605 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs543899973 | chr19:56276614-56276615 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs138487618 | chr19:56276638-56276639 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs200393737 | chr19:56276647-56276648 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs141934612 | chr19:56276653-56276654 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs540786296 | chr19:56276654-56276655 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs560539787 | chr19:56276667-56276668 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs114477088 | chr19:56276697-56276698 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs531043086 | chr19:56276728-56276729 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs181141708 | chr19:56276758-56276759 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs74990011 | chr19:56277000-56277001 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs568500949 | chr19:56277096-56277097 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs572638862 | chr19:56277128-56277129 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs75712418 | chr19:56277146-56277147 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs566359761 | chr19:56277204-56277205 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs538532489 | chr19:56277257-56277258 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs558464411 | chr19:56277258-56277259 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs115600863 | chr19:56277298-56277299 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs139978563 | chr19:56277310-56277311 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs113986252 | chr19:56277356-56277357 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs537805079 | chr19:56277358-56277359 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs373329138 | chr19:56277429-56277430 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs13344804 | chr19:56277430-56277431 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs574446171 | chr19:56277443-56277444 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs539981727 | chr19:56277456-56277457 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs576388458 | chr19:56277477-56277478 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs10420943 | chr19:56277494-56277495 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs546517645 | chr19:56277511-56277512 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs563130087 | chr19:56277523-56277524 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs532053385 | chr19:56277533-56277534 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs117909667 | chr19:56277538-56277539 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs543784835 | chr19:56277573-56277574 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs561965129 | chr19:56277587-56277588 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs7258127 | chr19:56277619-56277620 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs139831211 | chr19:56277667-56277668 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs145461034 | chr19:56277703-56277704 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs147685522 | chr19:56277727-56277728 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs529145779 | chr19:56277751-56277752 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs551959886 | chr19:56277752-56277753 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs148883622 | chr19:56277802-56277803 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs143542058 | chr19:56277811-56277812 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs7246212 | chr19:56277868-56277869 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs554527888 | chr19:56277878-56277879 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs567998240 | chr19:56277892-56277893 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Myelodysplastic syndrome | 17634407 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Cancer | 20164919 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Prostate cancer | 18632612 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Congenital nephrotic syndrome | 18421352 | CNVD |
Astrocytoma | 17934521 | CNVD |
Leukemia | 17361228 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Breast cancer | 17603634 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
renal disease | 20603712 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Salivary gland adenoid cystic carcinoma | 17545515 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Chordoma | 18071362 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Bladder cancer | 21909424 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Wilms tumour | 21544195 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18852474 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Cervical cancer | 21062161 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Prostate cancer | 16573809 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Lung cancer | 18438408 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Neuroblastoma | 20406844 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 20459607 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Lung cancer | 17086460 | CNVD |
Basal cell lymphoma | 19029149 | CNVD |
Diffuse large b-cell lymphoma | 19029149 | CNVD |
Myelofibrosis | 22110671 | CNVD |
T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
Alzheimer''s disease | 22166940 | CNVD |
Heart disease | 21282601 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Breast cancer | 21509527 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr19:56277000-56279600 | Enhancers | Primary monocytes fromperipheralblood | blood |
2 | chr19:56278000-56278200 | Bivalent Enhancer | Primary hematopoietic stem cells short term culture | blood |
3 | chr19:56279600-56280000 | Weak transcription | Primary monocytes fromperipheralblood | blood |
4 | chr19:56280000-56281800 | Enhancers | Primary monocytes fromperipheralblood | blood |
5 | chr19:56281200-56281800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |